Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Jonathan A. Ledermann(London Cancer), Cristiana Sessa(Institute of Oncology Research), Christina Fotopoulou(Ovarian Cancer Action), Antonio González-Martı́n(Spanish Ovarian Cancer Research Group), Nicoletta Colombo(University of Milano-Bicocca), F. Raja(Cancer Institute (WIA))
Cited by 1,115
Related Papers
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
|Annals of Oncology|2019|1.2k
<scp>FIGO</scp> staging of endometrial cancer: 2023
|International Journal of Gynecology & Obstetrics|2023|926